Raymond James Financial Services Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $482K | Buy |
6,864
+336
| +5% | +$23.6K | ﹤0.01% | 2642 |
|
|
2024
Q2 | $537K | Sell |
6,528
-885
| -12% | -$72.9K | ﹤0.01% | 2482 |
|
|
2024
Q1 | $647K | Buy |
7,413
+72
| +1% | +$6.29K | ﹤0.01% | 2330 |
|
|
2023
Q4 | $708K | Sell |
7,341
-14,508
| -66% | -$1.4M | ﹤0.01% | 2178 |
|
|
2023
Q3 | $1.93M | Buy |
21,849
+2,232
| +11% | +$197K | ﹤0.01% | 1520 |
|
|
2023
Q2 | $1.7M | Sell |
19,617
-3,288
| -14% | -$285K | ﹤0.01% | 1605 |
|
|
2023
Q1 | $2.23M | Buy |
22,905
+8,620
| +60% | +$838K | ﹤0.01% | 1424 |
|
|
2022
Q4 | $1.48M | Sell |
14,285
-955
| -6% | -$98.8K | ﹤0.01% | 1611 |
|
|
2022
Q3 | $1.29M | Buy |
15,240
+863
| +6% | +$73.2K | ﹤0.01% | 1676 |
|
|
2022
Q2 | $1.19M | Sell |
14,377
-2,461
| -15% | -$204K | ﹤0.01% | 1723 |
|
|
2022
Q1 | $1.3M | Buy |
16,838
+11,672
| +226% | +$900K | ﹤0.01% | 1773 |
|
|
2021
Q4 | $456K | Sell |
5,166
-5,068
| -50% | -$447K | ﹤0.01% | 2433 |
|
|
2021
Q3 | $791K | Sell |
10,234
-2,324
| -19% | -$180K | ﹤0.01% | 2110 |
|
|
2021
Q2 | $1.05M | Buy |
12,558
+4,765
| +61% | +$398K | ﹤0.01% | 1917 |
|
|
2021
Q1 | $588K | Buy |
7,793
+2,425
| +45% | +$183K | ﹤0.01% | 2181 |
|
|
2020
Q4 | $471K | Buy |
5,368
+1,120
| +26% | +$98.3K | ﹤0.01% | 2172 |
|
|
2020
Q3 | $323K | Sell |
4,248
-30
| -0.7% | -$2.28K | ﹤0.01% | 2230 |
|
|
2020
Q2 | $528K | Buy |
+4,278
| New | +$528K | ﹤0.01% | 1891 |
|
|
2020
Q1 | – | Sell |
-4,765
| Closed | -$403K | – | 2420 |
|
|
2019
Q4 | $403K | Buy |
+4,765
| New | +$403K | ﹤0.01% | 2116 |
|
|
2019
Q3 | – | Sell |
-2,400
| Closed | -$206K | – | 2783 |
|
|
2019
Q2 | $206K | Sell |
2,400
-925
| -28% | -$79.4K | ﹤0.01% | 2523 |
|
|
2019
Q1 | $295K | Buy |
3,325
+582
| +21% | +$51.6K | ﹤0.01% | 2250 |
|
|
2018
Q4 | $234K | Sell |
2,743
-725
| -21% | -$61.8K | ﹤0.01% | 2154 |
|
|
2018
Q3 | $336K | Buy |
3,468
+842
| +32% | +$81.6K | ﹤0.01% | 2202 |
|
|
2018
Q2 | $247K | Sell |
2,626
-497
| -16% | -$46.7K | ﹤0.01% | 2361 |
|
|
2018
Q1 | $253K | Buy |
3,123
+606
| +24% | +$49.1K | ﹤0.01% | 2128 |
|
|
2017
Q4 | $224K | Buy |
+2,517
| New | +$224K | ﹤0.01% | 2180 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 2525 |
|
|
2017
Q2 | – | Sell |
-11,288
| Closed | -$991K | – | 2482 |
|
|
2017
Q1 | $991K | Buy |
11,288
+7,461
| +195% | +$655K | 0.01% | 1193 |
|
|
2016
Q4 | $317K | Sell |
3,827
-3,958
| -51% | -$328K | ﹤0.01% | 1779 |
|
|
2016
Q3 | $720K | Sell |
7,785
-4,225
| -35% | -$391K | 0.01% | 1285 |
|
|
2016
Q2 | $934K | Buy |
12,010
+7,096
| +144% | +$552K | 0.01% | 1080 |
|
|
2016
Q1 | $405K | Buy |
+4,914
| New | +$405K | ﹤0.01% | 1367 |
|